Mold, Indoor Air Quality & Human Health

Understanding How Damp and Mold-Contaminated Buildings Affect the Human Body

Mold contamination is not merely a cosmetic building problem. Mold pollutes the indoor environment and affects the quality of the air occupants breathe. People living or working in damp and mold-contaminated buildings may be exposed continuously to microscopic mold spores, fungal fragments, allergens, beta-glucans, fungal enzymes, microbial volatile organic compounds, bacteria, endotoxins and, where toxin-producing molds and suitable environmental conditions are present, mycotoxins.

These contaminants are often invisible. Mold may be growing behind cupboards, beneath flooring, inside wall cavities, above ceilings, inside roof spaces, behind skirtings or within damp building materials. Occupants may therefore inhale contaminated indoor air for months or years without understanding why their health continues to deteriorate.

Mold Exposure Involves More Than Airborne Spores

Traditional discussions about mold exposure frequently focus only on visible mold and airborne spores. In reality, people inside a water-damaged building may be exposed to a far more complex mixture of biological particles, microbial gases and chemical contaminants.

• Viable and non-viable mold spores released from active or previously disturbed fungal growth
• Microscopic fungal fragments that may be considerably smaller than intact spores and capable of penetrating deeply into the respiratory system
• Beta-glucans and fungal cell-wall components capable of activating inflammatory and immune responses
• Fungal allergens, enzymes and proteins that may contribute to sensitisation, asthma, sinus disease and allergic reactions
• Microbial volatile organic compounds, or mVOCs, produced during active microbial metabolism
• Mycotoxins produced by certain fungal species under suitable environmental conditions
• Bacteria, endotoxins and microbial debris commonly associated with damp and deteriorating building materials
• Ordinary chemical VOCs and particulate matter released from wet, damaged or degrading materials

The health burden of a mold-contaminated building is therefore not determined by a single mold count or one laboratory result. The building must be considered as a complete indoor environment, including the moisture source, fungal ecology, hidden contamination, ventilation, humidity, airborne particulate load, chemical pollutants and the health vulnerability of the occupants.

Microbial Volatile Organic Compounds and Mold Odour

A musty, earthy or damp odour should never be dismissed simply because no visible mold can be found. Active microbial growth can release mVOCs into the indoor air. These gases are produced during fungal and bacterial metabolism and may move from concealed cavities into occupied rooms.

Exposure to mVOCs has been associated with irritation of the eyes, nose, throat and respiratory system, as well as headaches, dizziness, nausea, fatigue and difficulty concentrating. Odour intensity alone cannot identify the fungal species or determine the full health risk, but persistent mold odour is an important warning sign of concealed moisture and active microbial contamination.

Mold, Mycotoxins and Cellular Function

Scientific research has established that specific fungal components and mycotoxins can affect human cells through several biological pathways. These effects may include oxidative stress, inflammatory signalling, disruption of cellular membranes, interference with amino-acid metabolism and impairment of normal protein synthesis.

Certain mycotoxins can interfere with ribosomal activity and the production of proteins required for normal cellular function. Others may damage lipid membranes, structural proteins, DNA and the antioxidant systems used by cells to defend themselves against oxidative injury.

The effects depend on the fungal species, toxin produced, concentration, route of exposure, duration of exposure and the ability of the individual to detoxify and recover from the biological burden.

Mitochondrial Dysfunction and Cellular Energy

Mitochondria are responsible for producing much of the energy required for normal cellular function. They also help regulate immune signalling, inflammation, oxidative balance, tissue repair and cell survival.

Research has shown that certain mycotoxins can disrupt mitochondrial membrane potential, oxidative phosphorylation and normal energy production. This can reduce the production of adenosine triphosphate, or ATP, increase reactive oxygen species and contribute to cellular stress, inflammation, dysfunction or cell death.

Mitochondrial disruption provides an important biological pathway through which mold and mycotoxin exposure may contribute to fatigue, weakness, poor stamina, cognitive difficulties, impaired recovery and aggravation of existing chronic or inflammatory conditions.

Immune and Lymphocyte Function

Mold-contaminated buildings may affect the immune system through allergens, beta-glucans, fungal fragments, proteolytic enzymes, inflammatory compounds and mycotoxins. These exposures may activate innate immune responses, alter cytokine signalling, affect lymphocyte activity and contribute to persistent inflammation or impaired immune defence.

Individuals with asthma, allergies, autoimmune or inflammatory illness, chronic lung disease, diabetes, immune suppression, cancer, previous severe viral illness or other underlying vulnerabilities may react more severely than healthy occupants exposed to the same building.

This is one reason why members of the same household may experience very different health outcomes. One person may show mild irritation, while another develops persistent respiratory, neurological, inflammatory or systemic symptoms.

Neurological Effects and the Blood-Brain Barrier

Research continues to expand our understanding of the neurological effects associated with fungal toxins and prolonged exposure to mold-contaminated environments. Certain mycotoxins have demonstrated the ability to impair or cross the blood-brain barrier, disrupt mitochondrial function, increase oxidative stress and promote neuroinflammation.

These pathways are being investigated in relation to headaches, dizziness, memory difficulties, poor concentration, brain fog, altered mood, disturbed sleep, reduced cognitive performance and other neurological symptoms reported by occupants of water-damaged buildings.

The science of mold-related illness is continuing to develop, but the involvement of mitochondrial dysfunction, oxidative stress, immune dysregulation, neuroinflammation and cellular toxicity can no longer be reduced to a discussion of allergy alone.

Why Some People Become More Seriously Ill

A mold-contaminated building does not affect every occupant in the same way. The health outcome is determined by the interaction between the building, the contaminants present, the level and duration of exposure and the vulnerability of the individual.

People who may be more vulnerable include:

• Babies and young children
• Elderly occupants
• People with asthma, allergies or chronic respiratory disease
• People with autoimmune, inflammatory or immune-related conditions
• People with diabetes or metabolic illness
• People undergoing cancer treatment or taking immune-suppressing medication
• Organ-transplant recipients and other immunocompromised individuals
• People recovering from severe viral illness, including COVID-19
• People with existing neurological, mitochondrial or chronic fatigue-related conditions

The COVID-19 pandemic demonstrated how viral lung injury, diabetes, altered immunity, critical illness and corticosteroid exposure can combine to make individuals more vulnerable to environmental fungi. COVID-associated aspergillosis and mucormycosis confirmed that molds normally present in the environment can become dangerous when the body’s natural defences are impaired.

The Building Must Be Investigated

Medical treatment and environmental correction perform different but complementary roles. Doctors investigate and treat the patient. Mold Detection SA investigates the building and the environmental conditions that may be contributing to continued exposure.

Medication may reduce symptoms, control inflammation or treat a diagnosed infection, but it cannot repair a leaking roof, correct rising damp, remove concealed mold, reduce contaminated dust or restore healthy indoor air quality. Where exposure continues, symptoms may persist or repeatedly return.

A professional mold inspection identifies moisture defects, visible and hidden mold growth, structural dampness, water intrusion, ventilation problems and other conditions contributing to an unhealthy indoor environment. Where required, the assessment may include indoor air quality testing, airborne mold sampling, surface sampling or specialised laboratory analysis.

Once the source and extent of the contamination have been established, a structured mold remediation plan can be developed to remove the contamination, correct the moisture source and restore a healthier indoor environment.

---

Are You, Your Children or Other Family Members Continuously Ill?

Mold-related health symptoms can resemble many common illnesses. People living or working in damp and mold-contaminated buildings may repeatedly be treated for influenza, sinusitis, bronchitis, asthma, pneumonia, allergies, skin conditions or recurring respiratory infections without the environmental source of exposure being identified.

Mold exposure does not affect every person in the same way. The health outcome depends on the mold species and microbial contaminants present, the concentration and duration of exposure, the route through which exposure occurs and the existing health, immune function and genetic susceptibility of the individual.

Symptoms and Health Conditions Associated With Mold Exposure

Symptoms and conditions reported or medically associated with mold exposure, fungal sensitisation, fungal infection, mycotoxin exposure and prolonged occupation of water-damaged buildings may include:

• Flu-like symptoms and recurring feelings of illness
• Persistent or continuous coughing
• Runny or blocked nose
• Recurring sinusitis and sinus congestion
• Post-nasal drip, throat soreness and upper-airway irritation
• Chest tightness or a persistent closed-chest feeling
• Wheezing and difficulty breathing
• Frequent or worsening asthma attacks
• Bronchitis or pneumonia-like symptoms
• Recurring respiratory infections
• Eye irritation, including itchy, red or watery eyes
• Skin irritation, rashes, itching or aggravated eczema
• Headaches, dizziness and nausea
• Fatigue, weakness and reduced stamina
• Disturbed sleep and failure to recover normally after rest
• Brain fog, poor concentration and memory difficulties
• Mood changes, anxiety, irritability or reduced psychological wellbeing
• Aggravation of allergic, inflammatory or immune-related conditions
• Hypersensitivity pneumonitis and other immune-mediated lung conditions
• Allergic fungal sinusitis
• Allergic bronchopulmonary aspergillosis
• Chronic pulmonary fungal disease
• Invasive fungal disease in susceptible or immunocompromised individuals

Because many of these symptoms overlap with common illnesses, the environmental contribution may be missed. Medication may temporarily control inflammation, allergy or infection, but it cannot remove hidden fungal growth, structural dampness, contaminated dust, spores, fragments, mVOCs or mycotoxins from the building.

How Does Mold Enter and Affect the Body?

People can be exposed to mold, fungal metabolites and contaminated building dust through three principal routes:

• Inhalation – breathing in mold spores, microscopic fungal fragments, contaminated dust, mVOCs and other airborne pollutants.
  • Larger particles are commonly deposited in the nose, sinuses, throat and upper respiratory system.
  • Smaller particles and fungal fragments may penetrate more deeply into the bronchi and lower lungs.
  • Very small particles and soluble fungal metabolites may interact with lung tissue and, under certain conditions, enter systemic circulation.
• Touch and direct contact – contact with contaminated surfaces, clothing, bedding, furniture, dust or building materials may affect the skin, eyes and mucous membranes.
• Ingestion – fungal contaminants and mycotoxins may be swallowed through contaminated food, water, settled dust, hand-to-mouth contact or mucus cleared from the respiratory tract.

Most building-related exposure occurs through repeated inhalation. Mold growing behind cupboards, beneath flooring, above ceilings, inside wall cavities, under roof insulation or within damp materials can release spores, fungal fragments and microbial gases into occupied rooms for prolonged periods.

Respiratory and Pulmonary Effects

The respiratory system is often the first and most continuously exposed organ system in a mold-contaminated building. Airborne spores, fungal fragments, allergens, enzymes, beta-glucans, mVOCs and contaminated dust can irritate the upper and lower respiratory tract, activate allergic responses and aggravate existing lung disease.

Exposure may contribute to coughing, wheezing, shortness of breath, sinus inflammation, recurring chest infections, worsening asthma and chronic respiratory irritation. In sensitised individuals, mold exposure may contribute to allergic fungal sinusitis, allergic bronchopulmonary aspergillosis and hypersensitivity pneumonitis.

Persistent or severe inflammation of the lungs can, in some cases, contribute to pulmonary injury, reduced lung function, fibrosis or other chronic respiratory complications. Babies, children, elderly occupants and people with asthma or existing lung disease require particular caution.

Immune, Inflammatory and Multisystem Effects

Mold-contaminated buildings may affect immune function through repeated exposure to fungal allergens, beta-glucans, enzymes, microscopic fragments, mycotoxins, bacteria and endotoxins. These exposures may alter cytokine signalling, affect lymphocyte activity, activate innate immune pathways and contribute to persistent or poorly regulated inflammation.

People with existing autoimmune, allergic, inflammatory or immune-related conditions may experience worsening symptoms when they remain exposed to a water-damaged building. The environmental burden may also complicate recovery from chronic infections, viral illness, surgery, cancer treatment or other major health events.

Long-term and systemic health concerns associated with specific fungal toxins and prolonged exposure continue to include effects involving:

• Mitochondrial dysfunction and impaired cellular energy production
• Oxidative stress and damage to cellular and mitochondrial membranes
• Disruption of amino-acid metabolism and protein synthesis
• Immune and lymphocyte dysfunction
• Persistent inflammatory signalling
• Neuroinflammation and neurotoxicity
• Effects involving the blood-brain barrier
• Hematological and immunological disorders
• Hepatic, endocrine and renal toxicity
• Gastrointestinal and cardiovascular effects
• Cognitive, memory, mood and concentration difficulties
• Aggravation of existing chronic, inflammatory and immune-mediated illness

Chronic Inflammatory Response Syndrome

Some individuals exposed to water-damaged buildings develop a persistent multisystem inflammatory illness that extends far beyond ordinary allergy or respiratory irritation. This condition is commonly referred to as Chronic Inflammatory Response Syndrome, or CIRS.

CIRS is associated with an abnormal and continuing inflammatory response following exposure to biotoxins and microbial contaminants. Susceptible individuals may experience fatigue, cognitive impairment, headaches, respiratory symptoms, muscle and joint pain, neurological symptoms, sleep disturbance, temperature dysregulation, mood changes, visual sensitivity and a wide range of other multisystem complaints.

The condition is frequently associated with water-damaged buildings containing molds, fungal fragments, bacteria, endotoxins, actinomycetes and other inflammatory contaminants. Genetic susceptibility, immune regulation, previous illness and the duration of exposure may influence whether an occupant develops a persistent inflammatory response.

Medical assessment and building investigation must work together. Treatment of the patient may be unsuccessful or incomplete while exposure to the contaminated environment continues. Read more on our dedicated Chronic Inflammatory Response Syndrome page.

Lyme Disease, Coinfections and Mold Exposure

People living with Lyme disease and other chronic infections may be particularly vulnerable to the additional burden created by mold and water-damaged buildings. Lyme disease can affect immune regulation, neurological function, energy production and inflammatory pathways, while mold exposure may add further immune, mitochondrial and toxicological stress.

Where Lyme disease, tick-borne coinfections, CIRS, mycotoxin exposure and mold contamination occur together, symptoms may overlap and become difficult to separate. Fatigue, brain fog, headaches, neurological symptoms, joint and muscle pain, sleep disturbance, immune dysfunction and poor recovery may be influenced by more than one underlying condition.

A patient may continue to struggle despite appropriate medical treatment when the building remains contaminated. Environmental investigation is therefore an important part of understanding the total burden affecting a susceptible individual. Read more on our dedicated Lyme Disease and Mold Exposure page.

Specific Molds Can Cause Serious Disease

Environmental molds should not be dismissed merely because they occur naturally. Specific fungal genera and species are medically recognised as allergens, toxin producers, opportunistic pathogens or causes of chronic and invasive fungal disease.

Aspergillus

Aspergillus species may cause allergic sensitisation, worsening asthma, allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, chronic pulmonary aspergillosis and invasive aspergillosis. In vulnerable patients, invasive disease can damage lung tissue and spread beyond the respiratory system.

Mucorales

Mucorales can cause mucormycosis, a serious invasive fungal disease most commonly affecting people with uncontrolled diabetes, cancer, transplantation, severe immune suppression, critical illness or systemic corticosteroid exposure. The COVID-19 pandemic highlighted the danger created when viral illness, lung damage, diabetes, altered immunity and corticosteroid exposure occur together.

Fusarium

Fusarium species may cause allergic responses, eye infections, skin and nail infections, sinus and pulmonary disease and disseminated infection in severely immunocompromised patients. Certain Fusarium species also produce mycotoxins capable of affecting cellular, immune and neurological function.

Scedosporium and Lomentospora

Scedosporium and Lomentospora are recognised opportunistic molds capable of causing pulmonary, sinus, skin, soft-tissue, bone, neurological and disseminated infections. Some species are particularly difficult to treat because of resistance to commonly used antifungal medication.

Other Medically Important Molds

Alternaria, Cladosporium, Penicillium, Chaetomium, Stachybotrys, Curvularia, Bipolaris, Exophiala and other molds may contribute to allergic sensitisation, asthma, sinus disease, inflammatory reactions, toxin exposure or opportunistic infection depending on the species present and the vulnerability of the person exposed.

Detecting one of these organisms in a building does not by itself diagnose a medical infection. It does, however, demonstrate why mold results must be interpreted according to fungal identity, concentration, indoor amplification, building conditions and occupant vulnerability rather than total mold count alone.

Toxigenic Mold, Mycotoxins and Cancer Risk

The term “black mold” is often used broadly, but mold colour alone does not determine health risk. Dark-coloured mold may be allergenic, inflammatory, toxin-producing or opportunistically pathogenic, while dangerous fungal species may also appear green, grey, white, brown or other colours.

Certain fungal toxins are recognised carcinogenic hazards. Aflatoxins produced by specific Aspergillus species are established human carcinogens, particularly in relation to liver cancer. Other mycotoxins produced by Aspergillus, Penicillium, Fusarium and additional fungi continue to be investigated for their possible contribution to cancer, genetic damage, immune suppression and chronic disease.

The health significance of a mold-contaminated building must therefore be assessed according to the fungal species and metabolites present, the amount and duration of exposure, the route through which exposure occurs and the vulnerability of the occupants.

Who Is Most Vulnerable?

Although anyone may be affected by prolonged exposure, the following occupants may face increased risk:

• Babies and young children
• Elderly occupants
• Pregnant women
• People with asthma, allergies or chronic respiratory disease
• People with autoimmune, inflammatory or immune-related conditions
• People diagnosed with or suspected of having CIRS
• People with Lyme disease or other chronic infections
• People with diabetes or metabolic illness
• People undergoing cancer treatment
• Organ-transplant recipients
• People taking corticosteroids or other immune-suppressing medication
• People recovering from severe viral illness, including COVID-19
• People with existing neurological, mitochondrial or chronic fatigue-related conditions
• Any occupant whose symptoms improve when leaving the building and return after re-entry

Air Purification Can Assist — But It Cannot Remove the Source

A correctly selected HEPA air purifier may assist in reducing airborne mold spores, fungal fragments and other particulate contaminants. Depending on the filtration system, activated-carbon or specialised gas filtration may also reduce certain odours and gaseous pollutants.

An air purifier cannot remove concealed mold growth, repair water intrusion, correct structural dampness, clean contaminated cavities or replace professional remediation. It should be used as a supporting air-quality measure, not as a substitute for removing the source of contamination.

---

The Science of Mold and Human Health Continues to Evolve

Twenty years ago, mold was largely regarded as an allergen capable of causing hay fever, coughing and asthma. Today, scientific understanding has expanded considerably. Research now demonstrates that exposure to damp and mold-contaminated buildings involves far more than airborne mold spores alone.

Scientists continue to investigate the effects of fungal fragments, microbial volatile organic compounds (mVOCs), beta-glucans, fungal enzymes, bacterial endotoxins, inflammatory compounds and mycotoxins on the human body. Research is also expanding our understanding of mitochondrial dysfunction, oxidative stress, immune dysregulation, neuroinflammation, cellular toxicity and the interaction between environmental exposure and chronic disease.

Every Person Responds Differently

One of the greatest challenges in environmental medicine is that there is no single mold illness experienced by everyone. Two people may live in the same house, breathe the same indoor air and yet develop completely different symptoms. One may remain relatively unaffected while another develops severe respiratory disease, chronic fatigue, neurological symptoms or persistent inflammatory illness.

The health outcome depends on numerous factors including the fungal species present, the microbial contaminants released, the concentration and duration of exposure, genetics, immune function, age, existing medical conditions, nutritional status and the body’s ability to regulate inflammation and detoxification.

Why Research Continues to Expand

The COVID-19 pandemic demonstrated how environmental fungi can become life-threatening when immune function is altered. At the same time, research into CIRS, chronic inflammatory disease, Lyme disease, mitochondrial dysfunction, autoimmune conditions and environmental toxicology continues to expand our understanding of how mold exposure may influence susceptible individuals.

New fungal species continue to be recognised as human pathogens, while advances in molecular biology, immunology and environmental medicine are improving our understanding of how buildings influence human health. What was accepted as medical knowledge ten years ago has already changed significantly, and this field continues to evolve rapidly.

Our Philosophy

At Mold Detection SA we believe that healthy people begin with healthy buildings. Our approach recognises that medicine treats the patient while environmental investigation identifies and removes unnecessary exposure to mold, dampness and poor indoor air quality. We continue to monitor emerging scientific research and incorporate evidence-based developments into our investigation and interpretation methodologies.

---